ASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)ASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)ASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)

ASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)

No trades
See on Supercharts

Key facts today


AstraZeneca's CEO revealed plans for U.S. drug price cuts, including a Medicare project under review by the Trump administration.
AstraZeneca reported record revenue but did not raise its full-year guidance, disappointing some. Shares are up 0.5% at 10,840 pence amid U.S. tariff and pricing concerns.
AstraZeneca plans to invest $50 billion in the U.S. by 2030, which includes the establishment of a new manufacturing center in Virginia, marking its largest single manufacturing investment globally.
Analyze the impactAnalyze the impact
Market capitalization
‪222.72 B‬USD
0.90USD
‪6.25 B‬USD
‪48.03 B‬USD
Beta (1Y)
−0.02

About AstraZeneca PLC


CEO
Pascal Soriot
Headquarters
Cambridge
Founded
1992
ISIN
ARDEUT112489
FIGI
BBG000DDGBJ4
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Check out other big names from the same industry as AZND.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US46353AX6
ASTRAZENECA 20/50
Yield to maturity
7.12%
Maturity date
Aug 6, 2050
US46353AZ1
ASTRAZENECA 21/51
Yield to maturity
6.52%
Maturity date
May 28, 2051
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.86%
Maturity date
Sep 18, 2042
US46353AU2
ASTRAZENECA 18/48
Yield to maturity
5.84%
Maturity date
Aug 17, 2048
US46353AM0
ASTRAZENECA PLC 15/45
Yield to maturity
5.79%
Maturity date
Nov 16, 2045
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
4.93%
Maturity date
Sep 15, 2037
US46353AL2
ASTRAZENECA PLC 15/25
Yield to maturity
4.82%
Maturity date
Nov 16, 2025
A
US4636NAN3
ASTRAZEN.FI. 24/34
Yield to maturity
4.80%
Maturity date
Feb 26, 2034
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.72%
Maturity date
Mar 3, 2033
US46353AW8
ASTRAZENECA 20/30
Yield to maturity
4.68%
Maturity date
Aug 6, 2030
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
4.64%
Maturity date
May 28, 2031

See all AZND bonds